fundamental TSHA
Laporan keuangan Taysha Gene Therapies, Inc., termasuk pendapatan, pengeluaran, dan laba.
Total keuntungan TSHA untuk kuartal terakhir adalah 2.02 M USD, dan %13.09 lebih tinggi dibandingkan dengan kuartal sebelumnya. Pendapatan bersih dari Q4 24 adalah -18.79 M USD.
Q1 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
−150,00 M
−100,00 M
−50,00 M
0,00
50,00 M
Total pendapatan
Profit bruto / Gross profit
Pemasukan operasional
Pretax income
Pendapatan netto
Mata uang: USD
Q1 '20
Mar 2020
Q3 '20
Sep 2020
Q4 '20
Des 2020
Q1 '21
Mar 2021
Q2 '21
Jun 2021
Q3 '21
Sep 2021
Q4 '21
Des 2021
Q1 '22
Mar 2022
Q2 '22
Jun 2022
Q3 '22
Sep 2022
Q4 '22
Des 2022
Q1 '23
Mar 2023
Q2 '23
Jun 2023
Q3 '23
Sep 2023
Q4 '23
Des 2023
Q1 '24
Mar 2024
Q2 '24
Jun 2024
Q3 '24
Sep 2024
Q4 '24
Des 2024
TTM
Total pendapatanPertumbuhan YoY
4,71 M
—
2,40 M
—
4,75 M
—
3,60 M
+44,04%
3,41 M
−27,52%
1,11 M
−53,57%
1,79 M
−62,33%
2,02 M
−43,90%
8,33 M
−631,00 K
−703,00 K
−331,00 K
−366,00 K
−325,00 K
−300,00 K
−300,00 K
−304,00 K
−1,23 M
Profit bruto / Gross profitPertumbuhan YoY
4,08 M
—
1,69 M
—
4,42 M
—
3,24 M
+293,44%
3,09 M
−24,27%
812,00 K
−52,01%
1,49 M
−66,30%
1,72 M
−46,94%
7,10 M
−20,63 M
−25,08 M
−20,05 M
−19,04 M
−27,42 M
−22,11 M
−22,55 M
−21,65 M
−93,72 M
Pemasukan operasionalPertumbuhan YoY
−16,56 M
+66,39%
−23,38 M
+29,11%
−15,63 M
+37,65%
−15,80 M
+15,52%
−24,33 M
−46,93%
−21,30 M
+8,92%
−21,06 M
−34,71%
−19,93 M
−26,18%
−86,62 M
−1,06 M
−1,21 M
−101,45 M
63,54 M
269,00 K
371,00 K
−4,46 M
1,15 M
−2,68 M
Pretax incomePertumbuhan YoY
−17,62 M
+64,83%
−24,60 M
+27,38%
−117,09 M
−345,08%
47,74 M
—
−24,06 M
−36,54%
−20,93 M
+14,92%
−25,52 M
+78,20%
−18,79 M
−139,35%
−89,30 M
−17,62 M
−24,60 M
−117,09 M
47,74 M
−24,06 M
−20,93 M
−25,52 M
−18,79 M
−89,30 M
Pendapatan nettoPertumbuhan YoY
−17,62 M
+64,83%
−24,60 M
+27,38%
−117,09 M
−345,08%
47,74 M
—
−24,06 M
−36,54%
−20,93 M
+14,92%
−25,52 M
+78,20%
−18,79 M
−139,35%
−89,30 M
−17,62 M
−24,60 M
−117,09 M
47,74 M
−24,06 M
−20,93 M
−25,52 M
−18,79 M
−89,30 M
−0,28
+78,78%
−0,38
+54,62%
−0,93
−44,96%
0,26
—
−0,10
+62,67%
−0,09
+76,52%
−0,10
+89,77%
−0,09
−135,90%
−0,38
Laba Dilusian per Saham (Diluted EPS)Pertumbuhan YoY
−0,28
+78,78%
−0,38
+54,62%
−0,93
−44,96%
0,26
—
−0,10
+62,67%
−0,09
+76,52%
−0,10
+89,77%
−0,09
−135,90%
−0,38
63,26 M
64,24 M
125,70 M
186,96 M
231,25 M
232,82 M
267,82 M
204,94 M
—
63,26 M
64,24 M
125,70 M
186,96 M
231,25 M
232,82 M
267,82 M
204,94 M
—
EBITDAPertumbuhan YoY
−15,93 M
+67,50%
−22,68 M
+30,61%
−15,30 M
+38,23%
−15,43 M
+9,34%
−24,00 M
−50,71%
−21,00 M
+7,42%
−20,76 M
−35,66%
−19,63 M
−27,20%
−85,39 M
EBITPertumbuhan YoY
−16,56 M
+66,39%
−23,38 M
+29,11%
−15,63 M
+37,65%
−15,80 M
+15,52%
−24,33 M
−46,93%
−21,30 M
+8,92%
−21,06 M
−34,71%
−19,93 M
−26,18%
−86,62 M
−21,27 M
−25,78 M
−20,38 M
−19,40 M
−27,74 M
−22,41 M
−22,85 M
−21,95 M
−94,95 M